Inventor · disambiguated record
Antonio Gualberto
Also filed as: GUALBERTO ANTONIO
17 granted patents·19 pending applications·44 citations·filing 2003–2022
93Inventor score
Top patents by PatentIndex Score
36 records- 0194US9956215B1Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2017·Granted May 1, 2018·5 cites·30 claims
- 0292US10426767B2Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2018·Granted Oct 1, 2019·3 cites·34 claims
- 0392US9707221B2Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2016·Granted Jul 18, 2017·8 cites·23 claims
- 0489US10292979B2Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2018·Granted May 21, 2019·4 cites·28 claims
- 0589US10137121B2Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2017·Granted Nov 27, 2018·2 cites·30 claims
- 0688US10022364B2Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2017·Granted Jul 17, 2018·4 cites·14 claims
- 0787US11207314B2Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2018·Granted Dec 28, 2021·1 cites·17 claims
- 0887US10980793B2Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2019·Granted Apr 20, 2021·1 cites·30 claims
- 0986US10335404B2Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2017·Granted Jul 2, 2019·3 cites·24 claims
- 1085US10471055B2Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2016·Granted Nov 12, 2019·3 cites·28 claims
- 1182US2023089412A1Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1281US11291663B2Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2018·Granted Apr 5, 2022·1 cites·21 claims
- 1381US10806730B2Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2017·Granted Oct 20, 2020·1 cites·26 claims
- 1479US7618626B2Combination treatment for non-hematologic malignanciesPFIZER·Filed 2005·Granted Nov 17, 2009·5 cites·5 claims
- 1576US11124839B2Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2017·Granted Sep 21, 2021·1 cites·34 claims
- 1672US11541045B2Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2018·Granted Jan 3, 2023·0 cites·39 claims
- 1767US8940493B2Circulating tumor cell assayGUALBERTO ANTONIO·Filed 2007·Granted Jan 27, 2015·2 cites·2 claims
- 1865US2021381063A1Methods of treating cancer patients with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1964US2020191793A1Circulating tumor cell assayJANSSEN DIAGNOSTICS LLC·Filed 2019·Application pending·0 cites
- 2062US2024384356A1Biomarkers for sting agonists and methods of using the sameEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 2159US2024043928A1Biomarkers for myelodysplastic syndrome (mds) and methods of using the sameEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 2258US2023404987A1Method of treating breast cancerEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 2357US2015177252A1Circulating tumor cell assayVERIDEX LLC·Filed 2014·Application pending·0 cites
- 2457US2011014207A1Combination treatment for non-hematologic malignanciesPFIZER·Filed 2009·Application pending·0 cites
- 2554US2022002396A1Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2653US2022143006A1Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 2751US2022142983A1Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 2851US2022168296A1Methods of treating cancer with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 2950US2018011103A1Circulating tumor cell assayJANSSEN DIAGNOSTICS LLC·Filed 2017·Application pending·0 cites
- 3049US2022305001A1Methods of treating acute myeloid leukemia with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 3148US2005113302A1A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of useFiled 2003·Application pending·0 cites
- 3245US10760130B2Predictive biomarker for hypoxia-activated prodrug therapyMOLECULAR TEMPLATES INC·Filed 2015·Granted Sep 1, 2020·0 cites·9 claims
- 3345US2019119758A1Methods of selecting cancer patients for treatment with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 3445US2017326133A1Methods of treating myelodysplastic syndrome with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 3543US2022071941A1Therapies for squamous cell carcinomasKURA ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 3640US2016158253A1Treatment of pancreatic cancer with a combination of a hypoxia-activated prodrug and a taxaneTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antonio Gualberto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →